Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority tri (Q38996992)
Jump to navigation
Jump to search
scientific article published on 7 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority tri |
scientific article published on 7 June 2015 |
Statements
1 reference
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority tri (English)
1 reference
Rafael Rubio
1 reference
Antonio Rivero
1 reference
Ignacio Suárez-Lozano
1 reference
Melcior Riera
1 reference
Miriam Estébanez
1 reference
Jesús Santos
1 reference
José Sanz-Moreno
1 reference
Jesús Troya
1 reference
Ana Mariño
1 reference
Antonio Antela
1 reference
Herminia Esteban
1 reference
Santiago Moreno
1 reference
GESIDA 7011 Study Group
1 reference
7 June 2015
1 reference
1 reference
Identifiers
1 reference